[DISCLOSURE] Reyon Pharmaceutical (102460) announced on Feb. 25 that it has decided to invest 160 billion won (US$143 million) in building a new factory in Chungju, North Chungcheong Province “to advance capacity and to secure competitiveness by building a factory that meets current good manufacturing practice regulations enforced by US Food and Drug Administration.”
By Hwang You-mee (glamazon@heraldcorp.com)